A new MIGS in a new space

An investigator for the CyPass Micro-Stent offers advice on training, the learning curve and patient selection.

By Steven R. Sarkisian, Jr., MD

A new-venture integration plan

Quash hasty impulses; launching any product, service or surgery requires a complete, detailed blueprint to succeed.

By Robert Calandra, Contributing

Anterior segment imaging

AS-OCT vs. UBM vs. endoscope; case-based approaches

By Benjamin Bert, MD, FACS

BEST PRACTICES

Getting your headcount just right

By Andrew Maller, MBA, COE

Coding & Reimbursement

A heads-up on HEDIS

By Suzanne L. Corcoran, COE

Corneal hysteresis is gaining respect

The measurement may be a step forward in predicting glaucoma progression.

By Kenneth Chang, MS

Guest Editorial

The OCT-A Revolution

By SriniVas R. Sadda, MD

IN SO MANY WORDS

Zeiss’ Ludwin Monz

Instrument Insider

By Robert Stoneback, associate editor

Our applications of widefield imaging

How we use it every day.

By SriniVas R. Sadda, MD

Perimetry: Tech type proliferation

Here’s sage advice on dealing with readings.

By Anmol Lamba, MD

Quick Hits

By Robert Stoneback, associate editor

Resuscitating refractive surgery

With an ever-growing number of procedures, the need for education is essential.

By Nicole A. Lemanski, MD, Aaron

Rx Perspective

By Robert Stoneback, associate editor

Spotlight

By Robert Stoneback, associate editor

Technology reigns in oculoplastics, too

Some, like CT scans and MRIs, these surgeons have adopted. But then there is the Medpor Titan 3D orbital ...

By Charles Kim, MD, and

THE ENLIGHTENED OFFICE

The faceless thieves among us

By Cynthia Matossian, MD, FACS

This cancer doesn’t want to be found

Primary vitreoretinal lymphoma presents as chronic uveitis; it remains a challenge to identify.

By Edmund Tsui, MD

Viewpoint

Too many qualifiers

A Beginner’s Guide to DMEK

Acquiring the right tissue and technique for your patients

By By Sumit

A Safe, Effective Balance

Prescribing both generic and branded drugs, physicians weigh efficacy, adherence, and cost

Multifactorial Choices in Glaucoma

Considering drugs, pricing, and packaging in an area where long-term adherence is vitally important

Optimal Instruments for DMEK

Challenges encountered by early adopters prompted the creation of surgeon-friendly instruments to help improve outcomes

By By Thomas

The Future of Branded vs. Generic

Forecasting trends and innovations that will affect prescribing

The Role of Cost in the Branded vs. Generic Equation

Choices are often driven by financial considerations — for both patients and physicians

What Makes an Ophthalmic Generic Bioequivalent?

A researcher discusses how the FDA establishes the bioequivalence of generic ophthalmic drugs